Bristol/Sanofi Seek Settlement In Plavix Case
This article was originally published in The Pink Sheet Daily
Executive Summary
In an unexpected twist, the companies offer Apotex an additional eight months of exclusivity in the proposed settlement.
You may also be interested in...
Apotex Launches Generic Plavix
Bristol-Myers Squibb, Sanofi-Aventis may seek preliminary injunction against Apotex.
Apotex Launches Generic Plavix
Bristol-Myers Squibb, Sanofi-Aventis may seek preliminary injunction against Apotex.
Bristol/Sanofi's Plavix Settlement Faces Justice Department Criminal Investigation
Bristol's conduct relating to the settlement with Apotex was "appropriate," CEO Dolan maintains.